应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06606 诺辉健康
停牌 12-19 13:49:53
14.140
+0.000
0.00%
最高
14.140
最低
14.140
成交量
0.00
今开
14.140
昨收
14.140
日振幅
0.00%
总市值
64.73亿
流通市值
64.73亿
总股本
4.58亿
成交额
0.00
换手率
0.00%
流通股本
4.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
请回答2024丨诺辉健康董事长兼CEO朱叶青:早筛的意义是在长生命周期中体现价值
蓝鲸财经 · 12-09
请回答2024丨诺辉健康董事长兼CEO朱叶青:早筛的意义是在长生命周期中体现价值
诺辉健康常卫清、噗噗管和幽幽管三款产品获香港注册
财中社 · 11-19
诺辉健康常卫清、噗噗管和幽幽管三款产品获香港注册
诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品
阿斯达克财经 · 11-19
诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品
诺辉健康根据香港医疗仪器行政管理制度登记三款产品
智通财经 · 11-19
诺辉健康根据香港医疗仪器行政管理制度登记三款产品
诺辉健康(06606):蔡耀忠获委任为首席财务官
智通财经 · 10-30
诺辉健康(06606):蔡耀忠获委任为首席财务官
诺辉健康(06606.HK)委任首席财务官
阿斯达克财经 · 10-30
诺辉健康(06606.HK)委任首席财务官
诺辉健康(06606.HK)延发2024年中期业绩 续停牌
阿斯达克财经 · 09-30
诺辉健康(06606.HK)延发2024年中期业绩 续停牌
诺辉健康(06606)在所有重大方面正常进行业务营运
智通财经 · 09-27
诺辉健康(06606)在所有重大方面正常进行业务营运
诺辉健康:独立特别委员会结构变动,2024年中期业绩及报告发布延迟
金融界港股 · 09-27
诺辉健康:独立特别委员会结构变动,2024年中期业绩及报告发布延迟
诺辉健康(06606):孔江南已获委任为独立非执行董事
智通财经 · 09-27
诺辉健康(06606):孔江南已获委任为独立非执行董事
诺辉健康(06606)委任中汇安达为公司新核数师 继续停牌
智通财经 · 09-27
诺辉健康(06606)委任中汇安达为公司新核数师 继续停牌
不止一家!鹏华基金等多家机构调整诺辉健康估值
环球网 · 09-20
不止一家!鹏华基金等多家机构调整诺辉健康估值
造假疑云难散!CFO、德勤辞任,诺辉健康再遭调降估值
财华社 · 09-16
造假疑云难散!CFO、德勤辞任,诺辉健康再遭调降估值
首席财务官、审计机构同日辞职后,诺辉健康再遭公募下调估值
红星新闻 · 09-16
首席财务官、审计机构同日辞职后,诺辉健康再遭公募下调估值
狂降75%!诺辉健康财务官辞任引发信任危机 公募基金削低公司估值
券商中国 · 09-16
狂降75%!诺辉健康财务官辞任引发信任危机 公募基金削低公司估值
基金大事件|基金最新保有量数据发布!个人投资者涌入债券基金,发生了什么?
中国基金报 · 09-14
基金大事件|基金最新保有量数据发布!个人投资者涌入债券基金,发生了什么?
停牌169天,诺辉健康仍陷财务造假旋涡,股票估值遭“腰斩式”下调
蓝鲸财经 · 09-13
停牌169天,诺辉健康仍陷财务造假旋涡,股票估值遭“腰斩式”下调
同一只停牌股,基金公司给出的估值为何不一样?
新浪财经 · 09-13
同一只停牌股,基金公司给出的估值为何不一样?
又出手!下调近60%
中国基金报 · 09-12
又出手!下调近60%
诺辉健康停牌165天:核数师德勤、CFO同日辞职,年报难产,财务造假疑云难消
时代财经 · 09-12
诺辉健康停牌165天:核数师德勤、CFO同日辞职,年报难产,财务造假疑云难消
公司概况
公司名称:
诺辉健康
所属市场:
SEHK
上市日期:
--
主营业务:
New Horizon Health Ltd是一家主要从事结直肠癌、胃癌及宫颈癌筛查产品的研发、临床开发、测试营运及商业化业务的中国投资控股公司。该公司通过其自有网络、合同销售组织(CSO)以及由医疗诊所营运的网上销售或电子平台向客户销售常卫清、噗噗管及其他产品。该公司的幽幽管(一种基于粪便的自检胃癌筛查测试)和宫证清(一种非侵入性尿液宫颈癌家用筛查测试)产品处于开发阶段。
发行价格:
--
{"stockData":{"symbol":"06606","market":"HK","secType":"STK","nameCN":"诺辉健康","latestPrice":14.14,"timestamp":1734571212342,"preClose":14.14,"halted":3,"volume":0,"delay":0,"floatShares":457813108,"shares":457813108,"eps":-0.20097955,"marketStatus":"停牌","marketStatusCode":2,"change":0,"latestTime":"12-19 13:49:53","open":14.14,"high":14.14,"low":14.14,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.2587283814093093,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734595800000},"adr":0,"listingDate":1613577600000,"adjPreClose":14.14,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06606/wiki","defaultTab":"wiki","newsList":[{"id":"2490587717","title":"请回答2024丨诺辉健康董事长兼CEO朱叶青:早筛的意义是在长生命周期中体现价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2490587717","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490587717?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:45","pubTimestamp":1733730325,"startTime":"0","endTime":"0","summary":"转眼,2024年已接近尾声。放眼整个大健康产业,癌症早筛一直是个热门领域。12月5日,诺辉健康董事长兼CEO朱叶青在接受封面新闻专访时分享了自己的2024年关键词以及对2025年的展望。在他看来,早筛是终身的体检习惯,早筛的意义是在长生命周期中体现价值。朱叶青:2024年的感悟是,克服困难可以增长力气。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/246498","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1219","BK1574","06606"],"gpt_icon":0},{"id":"2484913975","title":"诺辉健康常卫清、噗噗管和幽幽管三款产品获香港注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2484913975","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484913975?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:48","pubTimestamp":1732009702,"startTime":"0","endTime":"0","summary":"财中社11月19日电诺辉健康(06606)发布自愿性公告,宣布其三款产品已根据香港医疗仪器行政管理制度成功注册。这三款产品包括常卫清、噗噗管和幽幽管,分别用于结直肠癌的筛查和幽门螺杆菌检测。随着香港政府推出结直肠癌筛查计划,并资助50至75岁无症状居民接受筛查,市场对早期癌症筛查的意识和需求正在不断提高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411193244354216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2484918507","title":"诺辉健康(06606.HK)根据香港医疗仪器行政管理制度登记三款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2484918507","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484918507?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:35","pubTimestamp":1732008900,"startTime":"0","endTime":"0","summary":"产品已根据医疗仪器行政管理制度于香港卫生署成功登记。MDACS为医疗仪器登记制度,据此,医疗仪器制造商及进口商在证明有关医疗仪器符合公认的安全及性能标准后,可自愿向卫生署登记其医疗仪器。公司股份已自3月28日起于联交所暂停买卖,并将继续暂停买卖直至履行复牌指引。(港股报价延迟最少十五分钟。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220113123125356_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220113123125356_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397881/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1219","06606","159891"],"gpt_icon":0},{"id":"2484990121","title":"诺辉健康根据香港医疗仪器行政管理制度登记三款产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2484990121","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484990121?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:31","pubTimestamp":1732008703,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)公布,于近期推出了公司的三款产品,即(i)常卫清,为一种专有非侵入性粪便FIT-DNA结直肠癌筛查测试产品;(ii)噗噗管,一种专有非侵入性粪便FIT筛查产品,用来测试与结直肠癌相关的血红蛋白生物标志物,及(iii)幽幽管(一种基于粪便样本幽门螺杆菌的筛查消费者自测产品)已根据医疗仪器行政管理制度(MDACS)于中华人民共和国香港特别行政区政府卫生署成功登记。MDACS为医疗仪器登记制度,据此,医疗仪器制造商及进口商在证明有关医疗仪器符合公认的安全及性能标准后,可自愿向卫生署登记其医疗仪器。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119173330abced0ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119173330abced0ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","06606","BK1574"],"gpt_icon":0},{"id":"2479273275","title":"诺辉健康(06606):蔡耀忠获委任为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2479273275","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479273275?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:48","pubTimestamp":1730281704,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)发布公告,蔡耀忠已获委任为公司首席财务官,自2024年11月1日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1203734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1219","06606"],"gpt_icon":0},{"id":"2479427519","title":"诺辉健康(06606.HK)委任首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2479427519","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479427519?lang=zh_cn&edition=full","pubTime":"2024-10-30 17:48","pubTimestamp":1730281680,"startTime":"0","endTime":"0","summary":"诺辉健康(06606.HK) 公布,蔡耀忠已获委任为首席财务官,自11月1日起生效。他曾任四环医药(00460.HK) 首席财务官及执行董事。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-30 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220113123128470_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220113123128470_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392532/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2471116988","title":"诺辉健康(06606.HK)延发2024年中期业绩 续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2471116988","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471116988?lang=zh_cn&edition=full","pubTime":"2024-09-30 10:26","pubTimestamp":1727663160,"startTime":"0","endTime":"0","summary":"诺辉健康(06606.HK) 公布,目前截至2023年12月31日止年度审计工作尚未恢复。因此截至2024年6月30日止六个月的中期业绩已延迟刊发,及该期间的中期报告亦已延迟寄发。该股将继续暂停买卖直至履行复牌指引。(ha/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220113123123949_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220113123123949_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1384862/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2470570321","title":"诺辉健康(06606)在所有重大方面正常进行业务营运","url":"https://stock-news.laohu8.com/highlight/detail?id=2470570321","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470570321?lang=zh_cn&edition=full","pubTime":"2024-09-27 18:34","pubTimestamp":1727433298,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)发布公告,公司为一间处于商业阶段的生物科技公司,主要从事研发及商业化创新癌症筛查产品,以应对中国癌症筛查行业尚未获满足的庞大医疗需求。于本公告日期,尽管公司股份暂停买卖,集团仍在所有重大方面正常进行业务营运。于本公告日期,截至2023年12月31日止年度的审计工作尚未恢复。因此,截至2024年6月30日止6个月的中期业绩(2024年中期业绩)已延迟刊发,及该期间的中期报告(2024年中期报告)亦已延迟寄发。此外,继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","BK1574","06606"],"gpt_icon":0},{"id":"2470706369","title":"诺辉健康:独立特别委员会结构变动,2024年中期业绩及报告发布延迟","url":"https://stock-news.laohu8.com/highlight/detail?id=2470706369","media":"金融界港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470706369?lang=zh_cn&edition=full","pubTime":"2024-09-27 18:30","pubTimestamp":1727433004,"startTime":"0","endTime":"0","summary":"金融界9月27日消息,诺辉健康公布,自2024年10月1日起,独立特别委员会将由五名独立非执行董事组成,包括新任命的孔江南女士。另一方面,因为截至2023年12月31日止年度的审计工作还未恢复,所以2024年截至6月30日的中期业绩(2024年中期业绩)发布已被延迟,该期间的中期报告(2024年中期报告)也已延迟发布。诺辉健康将在适当的时间发布公告,通知股东2024年中期业绩及报告的更新情况。\n\n\r\n 责任编辑:钟离","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/27183043583409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1219","06606"],"gpt_icon":0},{"id":"2470036617","title":"诺辉健康(06606):孔江南已获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2470036617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470036617?lang=zh_cn&edition=full","pubTime":"2024-09-27 18:23","pubTimestamp":1727432614,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)发布公告,吴虹已辞任独立非执行董事、薪酬委员会主席及提名委员会成员的职位;孔江南已获委任为独立非执行董事及独立特别委员会成员;孔江南已获委任为薪酬委员会主席;及孔江南已获委任为提名委员会成员,分别自2024年10月1日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2470708426","title":"诺辉健康(06606)委任中汇安达为公司新核数师 继续停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2470708426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470708426?lang=zh_cn&edition=full","pubTime":"2024-09-27 18:11","pubTimestamp":1727431894,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诺辉健康(06606)发布公告,鉴于德勤•关黄陈方会计师行辞任后出现公司核数师职位空缺,在审核委员会的建议下,董事会已议决,委任中汇安达会计师事务所有限公司(中汇安达)为公司新核数师,任期由2024年9月27日起生效,直至本公司下届股东周年大会结束为止(委任)。此外,公司股份继续停牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2468650748","title":"不止一家!鹏华基金等多家机构调整诺辉健康估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2468650748","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468650748?lang=zh_cn&edition=full","pubTime":"2024-09-20 10:33","pubTimestamp":1726799622,"startTime":"0","endTime":"0","summary":"诺辉健康自3月28日因年报难产而停牌,至今已近半年时间。不仅如此,诺辉健康的停牌对多只基金造成了影响。据公开数据显示,截至二季度末,有多只基金重仓持有诺辉健康,包括路博迈中国医疗健康股票、富国医药成长30股票等知名基金。由于诺辉健康的停牌,相关基金公司不得不重新评估其持有的诺辉健康股票价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.huanqiu.com/article/4JVs89c0aXB","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_huanqiu","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2467811579","title":"造假疑云难散!CFO、德勤辞任,诺辉健康再遭调降估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2467811579","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467811579?lang=zh_cn&edition=full","pubTime":"2024-09-16 19:38","pubTimestamp":1726486681,"startTime":"0","endTime":"0","summary":"近些年来,许多未盈利的生物科技企业借助第18A章成功登陆港股市场,上市后这类公司股票简称会添加标记“B”,以向投资者提示风险。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202409_1/7997c24b-ecdc-45bb-b6fd-51a1d75da017.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202409_1/7997c24b-ecdc-45bb-b6fd-51a1d75da017.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66e8189953243c06dc1d4a0d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2467897367","title":"首席财务官、审计机构同日辞职后,诺辉健康再遭公募下调估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2467897367","media":"红星新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467897367?lang=zh_cn&edition=full","pubTime":"2024-09-16 17:01","pubTimestamp":1726477260,"startTime":"0","endTime":"0","summary":"9月9日,诺辉健康连发两份公告,公司首席财务官高煜及审计机构德勤同日宣布辞任。事实上,诺辉健康停牌不到半年时间,已经两次遭到公募集中下调估值。7月10日,深交所公告称,将诺辉健康调出港股通标的证券名单。而德勤方面称,其一直提醒诺辉健康,圆满完成调查对于德勤评估2023年审计的完成时间至关重要。红星资本局注意到,截至目前,诺辉健康委聘的独立调查委员会尚未发布任何调查结果的信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409161701459f009602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409161701459f009602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06606","BK1219","BK1574"],"gpt_icon":0},{"id":"2467606855","title":"狂降75%!诺辉健康财务官辞任引发信任危机 公募基金削低公司估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2467606855","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467606855?lang=zh_cn&edition=full","pubTime":"2024-09-16 07:36","pubTimestamp":1726443405,"startTime":"0","endTime":"0","summary":"【狂降75%!财务官辞任引发信任危机 公募基金削低公司估值】在财务官和审计机构双双选择“割袍断义”后,基金公司对医药股诺辉健康的不信任达到了一个顶点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202409163183873795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["06606","BK1574","BK1219"],"gpt_icon":0},{"id":"2467998099","title":"基金大事件|基金最新保有量数据发布!个人投资者涌入债券基金,发生了什么?","url":"https://stock-news.laohu8.com/highlight/detail?id=2467998099","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467998099?lang=zh_cn&edition=full","pubTime":"2024-09-14 18:45","pubTimestamp":1726310700,"startTime":"0","endTime":"0","summary":">>时隔半年,基金最新保有量数据发布!9月13日,中国证券投资基金业协会公布了公募基金销售保有规模数据,2024年上半年,保有量数据新增了股票型指数基金保有量情况,蚂蚁基金、华泰证券、中信证券、天天基金等在这一指标中位居前四强。这意味着海富通基金此次对其估值下调的幅度也超过57%。今年5月,中信百信银行发布公告称,原行长李如东因工作调整辞任,董事会决定聘任寇冠为新任行长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656141253&idx=3&sn=a90b399bb8a6e79d0fbe8ccde84a9b3e&chksm=8a4179194c5109aee819b92f732cbfcad8bf126195036518c8e2eb838476ab8a330b6fab3c78&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656141253&idx=3&sn=a90b399bb8a6e79d0fbe8ccde84a9b3e&chksm=8a4179194c5109aee819b92f732cbfcad8bf126195036518c8e2eb838476ab8a330b6fab3c78&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","BK1574","06606"],"gpt_icon":0},{"id":"2467771122","title":"停牌169天,诺辉健康仍陷财务造假旋涡,股票估值遭“腰斩式”下调","url":"https://stock-news.laohu8.com/highlight/detail?id=2467771122","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467771122?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:42","pubTimestamp":1726238558,"startTime":"0","endTime":"0","summary":"蓝鲸新闻9月13日停牌169天后,诺辉健康再度陷入风波。9月13日,大成基金发布公告,对持有的诺辉健康股票进行了估值调整,下调幅度接近75%。作为风波中的另一方,诺辉健康曾头顶“中国癌症早筛第一股”的光环登陆港股市场。但此后,公司先是陷入财务造假风波,又因未能按期发布2023年年报停牌至今。9月9日,诺辉健康首席财务官高煜及审计机构德勤同日宣布辞任,诺辉健康的未来更加扑朔迷离。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/240256","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK1219","BK1574","06606"],"gpt_icon":0},{"id":"2467771427","title":"同一只停牌股,基金公司给出的估值为何不一样?","url":"https://stock-news.laohu8.com/highlight/detail?id=2467771427","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467771427?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:34","pubTimestamp":1726238065,"startTime":"0","endTime":"0","summary":"当一家上市公司持续停牌,作为持股方的基金公司,就需要对其进行估值调整。同一股票不同估值本周,多家基金公司发布公告,对旗下基金持有的 诺辉健康 进行估值调整。从上述5家基金公司给出的最新估值来看,除了路博迈,其余4家对诺辉健康较停牌前的股价下调幅度均超过50%。其中,大成基金下调幅度高达74.96%。可以看到,对于同一家停牌公司,基金公司给出的估值不尽相同,甚至差异较大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132240459efb01a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132240459efb01a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","06606","BK1574"],"gpt_icon":0},{"id":"2466214889","title":"又出手!下调近60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2466214889","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466214889?lang=zh_cn&edition=full","pubTime":"2024-09-12 12:33","pubTimestamp":1726115580,"startTime":"0","endTime":"0","summary":"按照光大资管的最新估值,诺辉健康的最新估值较停牌前下调了59.7%。这意味着海富通基金此次对其估值下调的幅度也超过57%。截至目前,独立调查委员会尚未发布任何调查结果相关的信息。尤其是今年的7月20日,诺辉健康被从“港股通”名单中剔除后,基金公司进一步下调对其估值。银华基金在7月30日将诺辉健康的股价下调至每股6.60港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656139746&idx=2&sn=1b462de37f89cc266b0e27439b25792e&chksm=8ac456380b64dfd2f7fb9d92439d48a82c17f03bbde7bdc01826bb367d266cf1e4bb79186474&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656139746&idx=2&sn=1b462de37f89cc266b0e27439b25792e&chksm=8ac456380b64dfd2f7fb9d92439d48a82c17f03bbde7bdc01826bb367d266cf1e4bb79186474&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1219","06606"],"gpt_icon":0},{"id":"2466029265","title":"诺辉健康停牌165天:核数师德勤、CFO同日辞职,年报难产,财务造假疑云难消","url":"https://stock-news.laohu8.com/highlight/detail?id=2466029265","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466029265?lang=zh_cn&edition=full","pubTime":"2024-09-12 10:02","pubTimestamp":1726106546,"startTime":"0","endTime":"0","summary":"停牌165天后,两则辞职公告将诺辉健康(06606.HK)再次置于舆论风口。9月9日,诺辉健康发布公告称,德勤·关黄陈方会计师行(下称“德勤”)已辞去本公司核数师的职务。同日,诺辉健康首席财务官(CFO)高煜和联席秘书莫明慧亦宣布从公司离职。今年3月28日,诺辉健康短暂停牌,同时宣布公司延迟发布2023年年报,并就公司财务数据等展开调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202409123181796760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1219","06606","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.3362},{"period":"ytd","weight":-0.3892}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"New Horizon Health Ltd是一家主要从事结直肠癌、胃癌及宫颈癌筛查产品的研发、临床开发、测试营运及商业化业务的中国投资控股公司。该公司通过其自有网络、合同销售组织(CSO)以及由医疗诊所营运的网上销售或电子平台向客户销售常卫清、噗噗管及其他产品。该公司的幽幽管(一种基于粪便的自检胃癌筛查测试)和宫证清(一种非侵入性尿液宫颈癌家用筛查测试)产品处于开发阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.163099},{"month":2,"riseRate":1,"avgChangeRate":0.189164},{"month":3,"riseRate":0,"avgChangeRate":-0.182229},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.012258},{"month":5,"riseRate":0.666667,"avgChangeRate":0.037768},{"month":6,"riseRate":0.666667,"avgChangeRate":0.132759},{"month":7,"riseRate":0,"avgChangeRate":-0.044736},{"month":8,"riseRate":0,"avgChangeRate":-0.272889},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.160802},{"month":10,"riseRate":0.666667,"avgChangeRate":0.015313},{"month":11,"riseRate":1,"avgChangeRate":0.165661},{"month":12,"riseRate":0,"avgChangeRate":-0.110431}],"exchange":"SEHK","name":"诺辉健康","nameEN":"NH HEALTH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺辉健康,06606,诺辉健康股票,诺辉健康股票老虎,诺辉健康股票老虎国际,诺辉健康行情,诺辉健康股票行情,诺辉健康股价,诺辉健康股市,诺辉健康股票价格,诺辉健康股票交易,诺辉健康股票购买,诺辉健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺辉健康(06606)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺辉健康(06606)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}